Selected research
Industry Growth & Trends
Global Genomics Products Industry Growth and Trends Forecast to 2032
Market perspective
The global Genomics Products market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Genomics Products is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Genomics Products is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Genomics Products is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Genomics Products include Zymo Research, Active Motif, Thermo Fisher Scientific, Cayman Chemical, Diagenode, Abcam, New England Biolabs, Merck & Co. and Qiagen, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Genomics Products market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Genomics Products market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Genomics Products market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Genomics Products.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Genomics Products market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Genomics Products Market by Company
Zymo Research
Active Motif
Thermo Fisher Scientific
Cayman Chemical
Diagenode
Abcam
New England Biolabs
Merck & Co.
Qiagen
Bio-Rad
Illumina
Agilent
Perkinelmer
Epizyme Inc.
CellCentric Ltd.
ValiRx plc
EpiGentek
Syndax Pharmaceuticals
Spectrum Pharmaceuticals
Promega
Novartis
Genomics Products Segment by Type
Reagents and Consumables
Bioinformatics and Software
Instruments and Systems
Others
Genomics Products Segment by Application
Pharmaceutical & Biotechnological
Companies Academic & Research Institutes Contract
Research Organizations
Others
Genomics Products Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Genomics Products market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Genomics Products and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Genomics Products.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Genomics Products manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Genomics Products in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Reagents and Consumables
- Bioinformatics and Software
- Instruments and Systems
- Others
Applications
- Pharmaceutical & Biotechnological
- Companies Academic & Research Institutes Contract
- Research Organizations
- Others
Companies covered
- Zymo Research
- Active Motif
- Thermo Fisher Scientific
- Cayman Chemical
- Diagenode
- Abcam
- New England Biolabs
- Merck & Co.
- Qiagen
- Bio-Rad
- Illumina
- Agilent
- Perkinelmer
- Epizyme Inc.
- CellCentric Ltd.
- ValiRx plc
- EpiGentek
- Syndax Pharmaceuticals
- Spectrum Pharmaceuticals
- Promega
- Novartis
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Genomics Products Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Genomics Products Sales Estimates and Forecasts (2021-2032)
- 1.3 Genomics Products Market by Type
- 1.3.1 Reagents and Consumables
- 1.3.2 Bioinformatics and Software
- 1.3.3 Instruments and Systems
- 1.3.4 Others
- 1.4 Global Genomics Products Market Size by Type
- 1.4.1 Global Genomics Products Market Size Overview by Type (2021-2032)
- 1.4.2 Global Genomics Products Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Genomics Products Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Genomics Products Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Genomics Products Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Genomics Products Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Genomics Products Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Genomics Products Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Genomics Products Industry Trends
- 2.2 Genomics Products Industry Drivers
- 2.3 Genomics Products Industry Opportunities and Challenges
- 2.4 Genomics Products Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Genomics Products Revenue (2021-2026)
- 3.2 Global Top Players by Genomics Products Sales (2021-2026)
- 3.3 Global Top Players by Genomics Products Price (2021-2026)
- 3.4 Global Genomics Products Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Genomics Products Major Company Production Sites & Headquarters
- 3.6 Global Genomics Products Company, Product Type & Application
- 3.7 Global Genomics Products Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Genomics Products Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Genomics Products Players Market Share by Revenue in 2025
- 3.8.3 2025 Genomics Products Tier 1, Tier 2, and Tier 3
4 Genomics Products Regional Status and Outlook
- 4.1 Global Genomics Products Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Genomics Products Historic Market Size by Region
- 4.2.1 Global Genomics Products Sales in Volume by Region (2021-2026)
- 4.2.2 Global Genomics Products Sales in Value by Region (2021-2026)
- 4.2.3 Global Genomics Products Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Genomics Products Forecasted Market Size by Region
- 4.3.1 Global Genomics Products Sales in Volume by Region (2027-2032)
- 4.3.2 Global Genomics Products Sales in Value by Region (2027-2032)
- 4.3.3 Global Genomics Products Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Genomics Products by Application
- 5.1 Genomics Products Market by Application
- 5.1.1 Pharmaceutical & Biotechnological
- 5.1.2 Companies Academic & Research Institutes Contract
- 5.1.3 Research Organizations
- 5.1.4 Others
- 5.2 Global Genomics Products Market Size by Application
- 5.2.1 Global Genomics Products Market Size Overview by Application (2021-2032)
- 5.2.2 Global Genomics Products Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Genomics Products Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Genomics Products Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Genomics Products Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Genomics Products Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Genomics Products Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Genomics Products Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Zymo Research
- 6.1.1 Zymo Research Company Information
- 6.1.2 Zymo Research Business Overview
- 6.1.3 Zymo Research Genomics Products Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Zymo Research Genomics Products Product Portfolio
- 6.1.5 Zymo Research Recent Developments
- 6.2 Active Motif
- 6.2.1 Active Motif Company Information
- 6.2.2 Active Motif Business Overview
- 6.2.3 Active Motif Genomics Products Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Active Motif Genomics Products Product Portfolio
- 6.2.5 Active Motif Recent Developments
- 6.3 Thermo Fisher Scientific
- 6.3.1 Thermo Fisher Scientific Company Information
- 6.3.2 Thermo Fisher Scientific Business Overview
- 6.3.3 Thermo Fisher Scientific Genomics Products Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Thermo Fisher Scientific Genomics Products Product Portfolio
- 6.3.5 Thermo Fisher Scientific Recent Developments
- 6.4 Cayman Chemical
- 6.4.1 Cayman Chemical Company Information
- 6.4.2 Cayman Chemical Business Overview
- 6.4.3 Cayman Chemical Genomics Products Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Cayman Chemical Genomics Products Product Portfolio
- 6.4.5 Cayman Chemical Recent Developments
- 6.5 Diagenode
- 6.5.1 Diagenode Company Information
- 6.5.2 Diagenode Business Overview
- 6.5.3 Diagenode Genomics Products Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 Diagenode Genomics Products Product Portfolio
- 6.5.5 Diagenode Recent Developments
- 6.6 Abcam
- 6.6.1 Abcam Company Information
- 6.6.2 Abcam Business Overview
- 6.6.3 Abcam Genomics Products Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 Abcam Genomics Products Product Portfolio
- 6.6.5 Abcam Recent Developments
- 6.7 New England Biolabs
- 6.7.1 New England Biolabs Company Information
- 6.7.2 New England Biolabs Business Overview
- 6.7.3 New England Biolabs Genomics Products Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 New England Biolabs Genomics Products Product Portfolio
- 6.7.5 New England Biolabs Recent Developments
- 6.8 Merck & Co.
- 6.8.1 Merck & Co. Company Information
- 6.8.2 Merck & Co. Business Overview
- 6.8.3 Merck & Co. Genomics Products Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 Merck & Co. Genomics Products Product Portfolio
- 6.8.5 Merck & Co. Recent Developments
- 6.9 Qiagen
- 6.9.1 Qiagen Company Information
- 6.9.2 Qiagen Business Overview
- 6.9.3 Qiagen Genomics Products Sales, Revenue and Gross Margin (2021-2026)
- 6.9.4 Qiagen Genomics Products Product Portfolio
- 6.9.5 Qiagen Recent Developments
- 6.10 Bio-Rad
- 6.10.1 Bio-Rad Company Information
- 6.10.2 Bio-Rad Business Overview
- 6.10.3 Bio-Rad Genomics Products Sales, Revenue and Gross Margin (2021-2026)
- 6.10.4 Bio-Rad Genomics Products Product Portfolio
- 6.10.5 Bio-Rad Recent Developments
- 6.11 Illumina
- 6.11.1 Illumina Company Information
- 6.11.2 Illumina Business Overview
- 6.11.3 Illumina Genomics Products Sales, Revenue and Gross Margin (2021-2026)
- 6.11.4 Illumina Genomics Products Product Portfolio
- 6.11.5 Illumina Recent Developments
- 6.12 Agilent
- 6.12.1 Agilent Company Information
- 6.12.2 Agilent Business Overview
- 6.12.3 Agilent Genomics Products Sales, Revenue and Gross Margin (2021-2026)
- 6.12.4 Agilent Genomics Products Product Portfolio
- 6.12.5 Agilent Recent Developments
- 6.13 Perkinelmer
- 6.13.1 Perkinelmer Company Information
- 6.13.2 Perkinelmer Business Overview
- 6.13.3 Perkinelmer Genomics Products Sales, Revenue and Gross Margin (2021-2026)
- 6.13.4 Perkinelmer Genomics Products Product Portfolio
- 6.13.5 Perkinelmer Recent Developments
- 6.14 Epizyme Inc.
- 6.14.1 Epizyme Inc. Company Information
- 6.14.2 Epizyme Inc. Business Overview
- 6.14.3 Epizyme Inc. Genomics Products Sales, Revenue and Gross Margin (2021-2026)
- 6.14.4 Epizyme Inc. Genomics Products Product Portfolio
- 6.14.5 Epizyme Inc. Recent Developments
- 6.15 CellCentric Ltd.
- 6.15.1 CellCentric Ltd. Company Information
- 6.15.2 CellCentric Ltd. Business Overview
- 6.15.3 CellCentric Ltd. Genomics Products Sales, Revenue and Gross Margin (2021-2026)
- 6.15.4 CellCentric Ltd. Genomics Products Product Portfolio
- 6.15.5 CellCentric Ltd. Recent Developments
- 6.16 ValiRx plc
- 6.16.1 ValiRx plc Company Information
- 6.16.2 ValiRx plc Business Overview
- 6.16.3 ValiRx plc Genomics Products Sales, Revenue and Gross Margin (2021-2026)
- 6.16.4 ValiRx plc Genomics Products Product Portfolio
- 6.16.5 ValiRx plc Recent Developments
- 6.17 EpiGentek
- 6.17.1 EpiGentek Company Information
- 6.17.2 EpiGentek Business Overview
- 6.17.3 EpiGentek Genomics Products Sales, Revenue and Gross Margin (2021-2026)
- 6.17.4 EpiGentek Genomics Products Product Portfolio
- 6.17.5 EpiGentek Recent Developments
- 6.18 Syndax Pharmaceuticals
- 6.18.1 Syndax Pharmaceuticals Company Information
- 6.18.2 Syndax Pharmaceuticals Business Overview
- 6.18.3 Syndax Pharmaceuticals Genomics Products Sales, Revenue and Gross Margin (2021-2026)
- 6.18.4 Syndax Pharmaceuticals Genomics Products Product Portfolio
- 6.18.5 Syndax Pharmaceuticals Recent Developments
- 6.19 Spectrum Pharmaceuticals
- 6.19.1 Spectrum Pharmaceuticals Company Information
- 6.19.2 Spectrum Pharmaceuticals Business Overview
- 6.19.3 Spectrum Pharmaceuticals Genomics Products Sales, Revenue and Gross Margin (2021-2026)
- 6.19.4 Spectrum Pharmaceuticals Genomics Products Product Portfolio
- 6.19.5 Spectrum Pharmaceuticals Recent Developments
- 6.20 Promega
- 6.20.1 Promega Company Information
- 6.20.2 Promega Business Overview
- 6.20.3 Promega Genomics Products Sales, Revenue and Gross Margin (2021-2026)
- 6.20.4 Promega Genomics Products Product Portfolio
- 6.20.5 Promega Recent Developments
- 6.21 Novartis
- 6.21.1 Novartis Company Information
- 6.21.2 Novartis Business Overview
- 6.21.3 Novartis Genomics Products Sales, Revenue and Gross Margin (2021-2026)
- 6.21.4 Novartis Genomics Products Product Portfolio
- 6.21.5 Novartis Recent Developments
7 North America by Country
- 7.1 North America Genomics Products Sales by Country
- 7.1.1 North America Genomics Products Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Genomics Products Sales by Country (2021-2026)
- 7.1.3 North America Genomics Products Sales Forecast by Country (2027-2032)
- 7.2 North America Genomics Products Market Size by Country
- 7.2.1 North America Genomics Products Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Genomics Products Market Size by Country (2021-2026)
- 7.2.3 North America Genomics Products Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Genomics Products Sales by Country
- 8.1.1 Europe Genomics Products Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Genomics Products Sales by Country (2021-2026)
- 8.1.3 Europe Genomics Products Sales Forecast by Country (2027-2032)
- 8.2 Europe Genomics Products Market Size by Country
- 8.2.1 Europe Genomics Products Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Genomics Products Market Size by Country (2021-2026)
- 8.2.3 Europe Genomics Products Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Genomics Products Sales by Country
- 9.1.1 Asia-Pacific Genomics Products Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Genomics Products Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Genomics Products Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Genomics Products Market Size by Country
- 9.2.1 Asia-Pacific Genomics Products Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Genomics Products Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Genomics Products Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Genomics Products Sales by Country
- 10.1.1 South America Genomics Products Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Genomics Products Sales by Country (2021-2026)
- 10.1.3 South America Genomics Products Sales Forecast by Country (2027-2032)
- 10.2 South America Genomics Products Market Size by Country
- 10.2.1 South America Genomics Products Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Genomics Products Market Size by Country (2021-2026)
- 10.2.3 South America Genomics Products Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Genomics Products Sales by Country
- 11.1.1 Middle East and Africa Genomics Products Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Genomics Products Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Genomics Products Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Genomics Products Market Size by Country
- 11.2.1 Middle East and Africa Genomics Products Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Genomics Products Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Genomics Products Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Genomics Products Value Chain Analysis
- 12.1.1 Genomics Products Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Genomics Products Production Mode & Process
- 12.2 Genomics Products Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Genomics Products Distributors
- 12.2.3 Genomics Products Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst